Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

VMCP-VBAP Regimen

Known as: Vincristine-Melphalan-Cytoxan-Prednisone (VMCP)/Vincristine-BCNU-Adriamycin-Prednisone (VBAP) Regimen 
A regimen consisting of vincristine, melphalan, cyclophosphamide and prednisone (VMCP) alternating with vincristine, carmustine (BCNU), doxorubicin… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Instituto do Coração do Hospital das Clínicas da FMUSP Endereço para correspondência Dr. Max Grinberg Av. Dr. Enéas de Carvalho… Expand
Is this relevant?
2005
2005
Survival of patients with multiple myeloma (MM) showed no improvement between the 1960s and 1990s. During the last decade, new… Expand
  • table 1
  • table 2
  • figure 2
  • figure 1
  • figure 3
Is this relevant?
Review
1999
Review
1999
Nonsecretory myeloma, which accounts for 1% to 5% of all myelomas, is characterized by the absence of detectable M-protein in… Expand
Is this relevant?
Highly Cited
1991
Highly Cited
1991
The efficacy of alternating vincristine, melphalan (M), cyclophosphamide, prednisone/vincristine, carmustine, doxorubicin, and… Expand
Is this relevant?
1989
1989
Thirty-three previously untreated patients with multiple myeloma were randomized to either a combination of recombinant… Expand
Is this relevant?
1986
1986
Four hundred forty previously untreated patients with active multiple myeloma were entered into a randomized trial (Southwest… Expand
Is this relevant?